Yin Xiaolan, Chai Zongtao, Sun Xiaoting, Chen Jin, Wu Xiufang, Yang Liying, Zhou Xiaobao, Liu Feng
Department of Radiotherapy, Changhai Hospital (Hongkou District) Affiliated with Naval Medical University, Shanghai 200081, P.R. China.
Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital Affiliated with Naval Medical University, Shanghai 200081, P.R. China.
Exp Ther Med. 2020 Apr;19(4):2757-2765. doi: 10.3892/etm.2020.8502. Epub 2020 Feb 7.
MicroRNA-96 (miR-96) has been revealed serve an oncogenic role in various types of cancer. However, the role of miR-96 in cholangiocarcinoma (CCA) development and progression is yet to be elucidated. Thus, the aim of the present study was to investigate the role of miR-96 in CCA. The expression pattern of miR-96 in CCA tissues and cell lines was evaluated using reverse transcription-quantitative PCR analysis. Kaplan-Meier curves and Cox regression analyses were conducted to investigate the prognostic significance of miR-96 in CCA. Cell Counting Kit-8 and Transwell assays were performed to identify the functions of miR-96. The association between miR-96 and metastasis suppressor-1 () was verified using a dual-luciferase assay. The results demonstrated that miR-96 expression levels were increased in CCA tissues and cell lines compared with those in adjacent normal tissues and normal human intrahepatic biliary epithelial cell lines, respectively. High expression levels of miR-96 were significantly associated with lymph node metastasis, differentiation and TNM stage. In addition, upregulated expression of miR-96 was associated with a poorer prognosis and was predicted to be a prognostic factor in patients with CCA. Overexpression of miR-96 promoted CCA cell proliferation, migration and invasion. Additionally, was identified as a direct target of miR-96. The results of the present study indicated the clinical and biological importance of miR-96 as an oncogene in CCA. miR-96 may represent an independent prognostic biomarker and may promote CCA cell proliferation, migration and invasion by targeting .
微小RNA-96(miR-96)已被揭示在多种类型的癌症中发挥致癌作用。然而,miR-96在胆管癌(CCA)发生发展中的作用尚待阐明。因此,本研究的目的是探讨miR-96在CCA中的作用。采用逆转录定量PCR分析评估miR-96在CCA组织和细胞系中的表达模式。进行Kaplan-Meier曲线分析和Cox回归分析以研究miR-96在CCA中的预后意义。采用细胞计数试剂盒-8和Transwell实验来确定miR-96的功能。使用双荧光素酶报告基因检测验证miR-96与转移抑制因子1()之间的关联。结果表明,与相邻正常组织和正常人肝内胆管上皮细胞系相比,miR-96在CCA组织和细胞系中的表达水平分别升高。miR-96的高表达水平与淋巴结转移、分化程度和TNM分期显著相关。此外,miR-96表达上调与较差的预后相关,并且被预测为CCA患者的一个预后因素。miR-96的过表达促进了CCA细胞的增殖、迁移和侵袭。此外,被确定为miR-96的直接靶标。本研究结果表明miR-96作为CCA中的一种癌基因具有临床和生物学重要性。miR-96可能代表一种独立的预后生物标志物,并且可能通过靶向促进CCA细胞的增殖、迁移和侵袭。